Art

J-GLOBAL ID：200902243763520805   Reference number：07A0515612

Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C

慢性C型肝炎患者に対する初期高用量インターフェロンとリバビリンおよびアマンタジンの3薬併用療法

Author (10)： UYAMA Hirokazu (Osaka Univ. Graduate School of Medicine, Osaka) ,  NAKAMURA Hideji (Hyogo Coll. of Medicine, Hyogo) ,  HAYASHI Eijiro (Kinki Central Hospital, Hyogo) ,  OGAWA Hiroyuki (Nishinomiya Municipal Central Hospital, Hyogo) ,  ENOMOTO Hirayuki (Nishinomiya Municipal Central Hospital, Hyogo) ,  YOSHIDA Kenya (Nishinomiya Municipal Central Hospital, Hyogo) ,  OKUDA Yorihide (Osaka Univ. Graduate School of Medicine, Osaka) ,  YAMAMOTO Mitsunari (Tondabayashi Hospital, Osaka, JPN) ,  HADA Toshikazu (Hyogo Coll. of Medicine, Hyogo) ,  HAYASHI Norio (Osaka Univ. Graduate School of Medicine, Osaka)
Material： Hepatology Research  (Hepatol Res)
Volume： 37  Issue： 5  Page： 325-330  Publication year： May. 2007 
JST Material Number： W1284A  ISSN： 1386-6346  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： bridged compound

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0515612&from=J-GLOBAL&jstjournalNo=W1284A") }}

JST classification (2)： Clinical application of antiviral drugs  (GW17050Z) ,  Drug therapy(=pharmacotherapy)for digestive system diseases  (GH05020G)

Substance index (2)： Ribavirin ,  Amantadine

Reference (43)：

• HU, KQ. Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection. J Viral Hepat. 2001, 8, 1-18
• CONJEEVARAM, HS. Prediction of a sustained beneficial response to interferon alpha therapy in chronic hepatitis C. Hepatology. 1995, 22, 1326-1329
• DAVIS, GL. Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology. 1997, 26, 122S-127S
• SHIRATORI, Y. Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group. Gastroenterology. 1997, 113, 558-566
• NAKAMURA, H. Initial daily interferon administration can gain more eradication of HCV-RNA in patients with chronic hepatitis C, especially with serum intermediate viral load. Hepatogastroenterology. 1999, 46, 1131-1139

Terms in the title (8)： 慢性C型肝炎 ,  患者 ,  初期 ,  高用量 ,  インターフェロン ,  リバビリン ,  アマンタジン ,  併用療法